Insider Transactions in Q3 2023 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2023
|
Mark A Gardner SVP of Molecular Gen & Oncol |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-3.97%
|
$14,616
$126.22 P/Share
|
|
Aug 15
2023
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.65%
|
$9,990
$135.23 P/Share
|
|
Jul 25
2023
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.35%
|
$6,336
$144.59 P/Share
|
|
Jul 25
2023
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
78
+0.42%
|
$11,232
$144.59 P/Share
|
|
Jul 25
2023
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.22%
|
$3,600
$144.59 P/Share
|
|
Jul 14
2023
|
Sam Samad Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,909
-19.18%
|
$547,260
$140.18 P/Share
|